Hypertension, cognitive decline, and dementia: an epidemiological perspective

Hypertension is a known risk factor for stroke, and thus for vascular dementia. However, recent large observational studies have suggested that high blood pressure may also play a role in Alzheimer's disease. The mechanisms linking hypertension to Alzheimer's disease remain to be elucidated, but white matter lesions seen on cerebral magnetic resonance imaging appear to be a good marker of this association. It is not yet clearly established whether lowering blood pressure reduces the risk of white matter lesions and dementia, so large trials dealing with this question are eagerly awaited. These future trials could confirm the hope that, by lowering blood pressure, we may have a preventive treatment for dementia. This issue is of major importance, as the number of cases of dementia is expected to rise sharply in the near future.

[1]  M Prencipe,et al.  Stroke, disability, and dementia: results of a population survey. , 1997, Stroke.

[2]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[3]  E. Shimosegawa,et al.  Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. , 1997, Stroke.

[4]  W. O'Fallon,et al.  Dementia after ischemic stroke , 1996, Neurology.

[5]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[6]  K. Jellinger Parkinsonism due to binswanger's subcortical arteriosclerotic encephalopathy , 1996, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[8]  M. Mindach Low cerebral blood flow velocity and risk of white matter hyperintensities , 2001, Annals of Neurology.

[9]  T. Bekinschtein,et al.  White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  L. Beckett,et al.  Current and remote blood pressure and cognitive decline. , 1999, JAMA.

[11]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[12]  Robert Barber,et al.  A neuropathological study of periventricular white matter hyperintensities in major depression. , 2003, Journal of affective disorders.

[13]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[14]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[15]  D. Briley,et al.  Older people with impaired mobility have specific loci of periventricular abnormality on MRI. , 2002, Neurology.

[16]  J. V. van Swieten,et al.  Hypertension in the elderly is associated with white matter lesions and cognitive decline , 1991, Annals of neurology.

[17]  D. Leys,et al.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. , 1997, Stroke.

[18]  L R White,et al.  Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. , 1990, Journal of clinical epidemiology.

[19]  Frederik Barkhof,et al.  White matter lesions and hippocampal atrophy in Alzheimer’s disease , 2004, Neurology.

[20]  H Lechner,et al.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.

[21]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[22]  M. Kaste,et al.  Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. , 1997, Stroke.

[23]  A. Hofman,et al.  The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization , 2004, Journal of hypertension.

[24]  J. Jolles,et al.  Can the blood pressure predict cognitive task performance in a healthy population sample? , 1997, Journal of hypertension.

[25]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[26]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[27]  H. Yamanouchi,et al.  Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. , 1997, Stroke.

[28]  J. Staessen,et al.  Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. , 2004, American journal of hypertension.

[29]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[30]  M. O’Sullivan,et al.  Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.

[31]  J. Trojanowski,et al.  Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. , 1988, AJR. American journal of roentgenology.

[32]  Philip Scheltens,et al.  Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study , 2004, Hypertension.

[33]  D. Leys,et al.  Poststroke dementia , 2001, Neurology.

[34]  G. Baron,et al.  Leukoaraiosis and mobility decline: a high resolution magnetic resonance imaging study in older people with mild cognitive impairment , 2004, Neuroscience Letters.

[35]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[36]  E. Corder,et al.  Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. , 2000, Stroke.

[37]  R. Baloh,et al.  A prospective study of cerebral white matter abnormalities in older people with gait dysfunction , 2001, Neurology.

[38]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[39]  J F Toole,et al.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.

[40]  D. Bennett,et al.  Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.

[41]  B. Cesana,et al.  Dementia after first stroke. , 1996, Stroke.

[42]  James R. MacFall,et al.  Localization of age-associated white matter hyperintensities in late-life depression , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[44]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[45]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[46]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[47]  E P Steinberg,et al.  Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.

[48]  L. Ferrucci,et al.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. , 2001, American journal of epidemiology.

[49]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[50]  L. Hebert,et al.  Relation of blood pressure to cognitive function in the elderly. , 1991, American journal of epidemiology.

[51]  Y. Stern,et al.  Frequency and clinical determinants of dementia after ischemic stroke , 2000, Neurology.

[52]  F. Fazekas,et al.  Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study , 1997, Journal of the Neurological Sciences.

[53]  B. Tress,et al.  Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study , 1998, BMJ.

[54]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[55]  E Rostrup,et al.  Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.

[56]  C B Hall,et al.  Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.

[57]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[58]  R. Mayeux,et al.  Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.

[59]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[60]  Norman J Beauchamp,et al.  White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.

[61]  L. Hansson Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[62]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[63]  A Capdevila,et al.  Leuko-araiosis on magnetic resonance imaging and speed of mental processing. , 1990, Archives of neurology.

[64]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[65]  D. Kildea,et al.  Is senile dementia "age-related" or "ageing-related"? —evidence from meta-analysis of dementia prevalence in the oldest old , 1995, The Lancet.

[66]  S. Marenco,et al.  Regional Cerebral Blood Flow in Chronic Hypertension: A Correlative Study , 1993, Stroke.

[67]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[68]  C. Dufouil,et al.  Cognitive decline in individuals with high blood pressure , 1999, Neurology.

[69]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[70]  Sudha Seshadri,et al.  Dementia After Stroke: The Framingham Study , 2004, Stroke.

[71]  K. Wong,et al.  Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[72]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[73]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.

[74]  M. Prince,et al.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults , 1996, BMJ.

[75]  A. Hofman,et al.  Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.

[76]  B. Fagerberg,et al.  Cognitive Impairment and Dementia 20 Months after Stroke , 2004, Neuroepidemiology.

[77]  R. D'Agostino,et al.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.

[78]  L. Harrell,et al.  The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. , 1991, Archives of neurology.

[79]  C. Reynolds,et al.  Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.

[80]  E Auffray,et al.  Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.

[81]  B. Winblad,et al.  Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. , 1999, Archives of neurology.

[82]  J. Lodder,et al.  Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions , 1998, Movement disorders : official journal of the Movement Disorder Society.

[83]  G. Román From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. , 1996, Stroke.

[84]  J. V. van Swieten,et al.  Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.

[85]  V. Hachinski,et al.  Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[86]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.

[87]  R. Mayeux,et al.  Dementia after stroke , 1992, Neurology.

[88]  R. Mayeux,et al.  Risk of dementia after stroke in a hospitalized cohort , 1994, Neurology.

[89]  I. Deary,et al.  Brain white matter lesions detected by magnetic resosnance imaging are associated with balance and gait speed , 2003 .

[90]  B Horwitz,et al.  White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. , 1990, Archives of neurology.

[91]  E. Kaplan,et al.  Blood pressure and cognitive performance. The Framingham Study. , 1987, American journal of epidemiology.

[92]  A. Elster,et al.  Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. , 1998, Archives of neurology.

[93]  James R. MacFall,et al.  Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects , 2003, Biological Psychiatry.

[94]  P. J. Koudstaal,et al.  Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe , 2005, Neurology.

[95]  B. Winblad,et al.  Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up. , 1998, Journal of clinical epidemiology.